Conference Coverage
Stay Ahead of Emerging Data and Competitor Signals with Timely Conference Intelligence
Scientific and medical conferences shape the competitive and clinical landscape. Thelansis provides structured, timely coverage of global conferences to keep your teams informed about new data releases, pipeline shifts, and evolving treatment paradigms.
We monitor key sessions, posters, presentations, and KOL discussions across relevant congresses to deliver insights that directly inform development and commercial strategy.
What We Do:
Our experts provide comprehensive coverage including:
- Daily summaries of key sessions and data releases
- Competitor pipeline updates and interpretation
- Insights into innovative trial designs and endpoints
- KOL perspectives and emerging scientific opinions
- Strategic implications for your therapeutic areas
- Flash notes, rapid updates, and in-depth post-conference reports
In the current scenario, the competitive landscape of oncology TA, where innovation moves rapidly, pharma companies face intense pressure to optimize their pipeline investments. With hundreds of potential cancers and limited resources, selecting the most promising therapeutic indications for early-stage assets is both critical and complex. Traditional prioritization methods usually rely on manual literature reviews, expert panels, and historical analogs, lagging to keep pace with the dynamic nature of clinical, regulatory, and market data, which in turn delays portfolio actions.
Learn more: Smart Pipeline Decisions: AI-Powered Indication Prioritization for Oncology TA
A US-based mid-size biotech firm was preparing for its upcoming investment cycle to broaden its therapeutic area focus. The team had strong scientific instincts but lacked a unified, evidence-based approach to compare opportunities across disease areas, evaluate commercial risk, and pressure-test assumptions in volatile market conditions. Their existing datasets were scattered, inconsistent, and not structured to support quick, high-stakes investment calls.
Learn more: Optimizing Biotech Investment Strategy in an Uncertain Market Landscape
We Provide Answers to Critical Questions:
Our conference intelligence distills what matters and not just what happened, translating scientific developments into strategic relevance.
How does new competitor data impact our strategy or timelines?
What emerging mechanisms or modalities are gaining momentum?
Which trial design innovations should we consider?
What scientific trends may reshape future standards of care?
Need customize support?
Thelansis also caters to your specific needs by providing customized reports that satisfy your organizational requirements. Get on-demand customization of the report’s scope to exactly meet your needs.